Can special diet help biliary atresia babies grow? new study investigates
NCT ID NCT05072626
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how a special high-MCT (medium-chain triglyceride) diet affects growth in infants with biliary atresia after Kasai surgery. Researchers will track weight and length in 300 babies under 3 months old. The goal is to gather information, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2021
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The Kasai procedure for infants with biliary atresia under the age of 3 months.
- Ages
-
Up to 3 months
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: The Kasai procedure for infants with biliary atresia under the age of 3 months. Exclusion Criteria: * Complicated with cirrhosis, hepatitis, or other hepatic disorders; * Complicated with other systemic serious diseases (such as congenital multiple malformations, chromosome abnormalities)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Biliary atresia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Children's Hospital of Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can stem cells help infants with biliary atresia avoid a liver transplant?
- Could lying on the stomach help infants breathe easier?
- AI decodes baby poop to unlock digestive health secrets
- A drop of blood could spot a deadly liver disease in newborns
- What drives a rare liver disease in newborns? a genetic deep dive aims to find out
- Diaper photos may spot hidden liver disease in babies